Clinical Trial

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2020-02-03; most recent amendment 2026-04-30.
Status change: Recruiting → Active, Not Recruiting 2024-02-20
Status change: Not Yet Recruiting → Recruiting 2021-06-11
Trial Details
NCT Number NCT04255966
Lead Sponsor Aesculap AG
Conditions Osteolysis, Arthroplasty Complications, Instability of Prosthetic Joint, Degenerative Osteoarthritis, Rheumatic Arthritis, Fractures, Hip, Femoral Head Avascular Necrosis, Prosthesis Failure
Enrollment 60 participants
Start Date 2021-04-12
Primary Completion 2023-08-16 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-06